The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak

Viruses
Scott A FosterRandall Lanier

Abstract

Smallpox (variola) virus is considered a Category A bioterrorism agent due to its ability to spread rapidly and the high morbidity and mortality rates associated with infection. Current recommendations recognize the importance of oral antivirals and call for having at least two smallpox antivirals with different mechanisms of action available in the event of a smallpox outbreak. Multiple antivirals are recommended due in large part to the propensity of viruses to become resistant to antiviral therapy, especially monotherapy. Advances in synthetic biology heighten concerns that a bioterror attack with variola would utilize engineered resistance to antivirals and potentially vaccines. Brincidofovir, an oral antiviral in late stage development, has proven effective against orthopoxviruses in vitro and in vivo, has a different mechanism of action from tecovirimat (the only oral smallpox antiviral currently in the US Strategic National Stockpile), and has a resistance profile that reduces concerns in the scenario of a bioterror attack using genetically engineered smallpox. Given the devastating potential of smallpox as a bioweapon, preparation of a multi-pronged defense that accounts for the most obvious bioengineering possibilities...Continue Reading

References

Apr 1, 1992·Clinical Microbiology Reviews·B Bean
Jan 1, 1997·Annual Review of Microbiology·E Domingo, J J Holland
Jun 15, 1999·JAMA : the Journal of the American Medical Association·D A HendersonK Tonat
Mar 19, 2002·Antimicrobial Agents and Chemotherapy·Earl R KernKarl Y Hostetler
Apr 30, 2004·The New England Journal of Medicine·Roy M GulickUNKNOWN AIDS Clinical Trials Group Study A5095 Team
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Wendy C MageeDavid H Evans
Sep 16, 2006·Journal of Virology·Graciela AndreiDavid H Evans
Aug 10, 2007·Journal of Virology·Mathew M AdamsR W Moyer
Aug 29, 2007·Antimicrobial Agents and Chemotherapy·Debra C QuenelleEarl R Kern
Apr 19, 2011·Viruses·Randall LanierGeorge Painter
Jun 25, 2014·Antimicrobial Agents and Chemotherapy·Victoria A OlsonInger K Damon
Jan 30, 2015·The Journal of Antimicrobial Chemotherapy·Sophie DuraffourRobert Snoeck
Nov 1, 2016·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Paul GazzaniDavid V Milford
Jul 15, 2017·Science·Kai Kupferschmidt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Stephen C HarrisonJulie Theriot
GP
K D ROGERS, A M HARMUTH
Indian Medical Gazette
Clinics in Dermatology
A S Klainer
California State Journal of Medicine
© 2022 Meta ULC. All rights reserved